TP53 and clear cell adenocarcinoma: Additionally, there were two cases of high-grade EC with aberrant p53 expression (1.0%) and one case each of clear cell carcinoma, endometrial gastric-type carcinoma, and endometrial mesonephric-like carcinoma (each at 0.5%, 1/192).